(Date:8/29/2008)...ug. 29 /PRNewswire-FirstCall/ -- Landauer, Inc. (N...ors declared a regular,quarterly cash dividend of ...008. The dividend will be paid on October 3, 2008,... About Landauer, Landauer is the leading provide... and environmental radiation exposure. For more th...
(Date:8/29/2008)...fic obligation reduced from $250 to $19 million, ...oston Scientific,Corporation (NYSE: BSX ) today a... Texas found two patents of Medtronic, Inc. (NYSE:...ng the prosecution of the patents,before the Unite... previously found that certain Boston Scientific b...
(Date:8/29/2008)... Dr. Milton Owens and the Coastal Center for O...ia to provide protection for cash paying patients ...ic community is benefiting. , .... Milton Owens and the Coastal Center for Obesity ...rovide protection for cash paying patients in the ...
(Date:8/29/2008)... Trusted life science software provider allows...ngage via GSA. , Reston, ...erging software engineering firm dedicated to the...ral Services Administration (GSA) Contract. The GS...h the ability to conveniently engage 5AM Solutions...
Breaking Medicine News(10 mins):Health News:Court Rejects Two Medtronic Patents 2Health News:Court Rejects Two Medtronic Patents 3Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2...development at Sandia National Laboratories can id...rax in less than five minutes. //Sandia's Laborato...rted the work. Sandia is a multiprogram laboratory...kheed Martin company, for the U.S. Department of E...
...ng great covenant in dental restorative work, say ... and Technology at Ohio.//This ACP has new physica... researcher at OSU. “It’s more soluble than other ...to the stable dental mineral hydroxyapatite, which...
... and Iceland's National University Hospital, ascer...ses a woman's risk by more than 62 per cent.//Endo... tissue, which is normally found only in the linin...he tissue attaches itself to ligaments and organs ...
...e today are more at risk of developing stomach can...earchers at the University of Newcastle believe th... have robbed it off its anti-cancer agents. The r...h indicates that Aspirin may be effective in fight...
Other Medicine News:(Date:8/26/2008)...h Innovative Manufacturing - Has Potential to ...ess, ROCKVILLE, Md., Aug. 26 /PRNewswire-FirstCal...ay favorable results from the second stage of,the ...nfluenza virus-like,particle (VLP) vaccine candida...t, induced robust neutralizing antibody responses....
(Date:8/25/2008)...tion and Treatment Strategies--, PHILADELPHIA, Au...iscovered gene mutations that are the main cause o...uroblastoma. In addition, the researchers found,th...igh-risk forms of,non-inherited neuroblastoma, the...y enables us to offer the first genetic tests to f...
(Date:8/25/2008)...25 /- Anthera Pharmaceuticals,Inc., a...ng,anti-inflammatory drugs, today announced the in...onary events with Near-term Cardiovascular,Inflamm...ine the impact of,varespladib when administered to...drome (ACS) event., The FRANCIS trial is designed...
(Date:8/22/2008)... 22 /-, - Dangerous Bacteria Infect ...mes something well-tried can also be innovative: a... be very antimicrobial. This,ability is now playin...ous,hospital germs. In a worldwide noted field tes...n Wandsbek in Hamburg, Germany, was equipped with,...
Breaking Medicine Technology:Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 4Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 5Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 6Gene That Causes Childhood Cancer Neuroblastoma Is Found 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 3Gene That Causes Childhood Cancer Neuroblastoma Is Found 4Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 3ev3 Inc to Report 2007 Fourth Quarter and Full Year Financial Results and Host Conference Call on February 22 2008 3139 1ev3 Inc to Report 2007 Fourth Quarter and Full Year Financial Results and Host Conference Call on February 22 2008 3139 2Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 11383 1Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 11383 2Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 11383 3Mylan Restores Availability of Generic Levothyroxine in Florida 11381 1Mylan Restores Availability of Generic Levothyroxine in Florida 11381 2MBF Healthcare Acquisition Corp to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings 11379 1MBF Healthcare Acquisition Corp to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings 11379 2MBF Healthcare Acquisition Corp to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings 11379 3MBF Healthcare Acquisition Corp to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings 11379 4... Antiangiogenic Activity Demonstrated in,Preclinic...d., April 17, 2007 /PRNewswire-FirstCall/ --,Entre...y developing,therapeutics for the treatment of can... presentation of preclinical data for its,clinical...,presented by EntreMed scientists and collaborator...
...BRIDGE, Mass.--(BUSINESS WIRE)--Apr 17, 2007 -,AVE...ny focused on,the discovery and development of nov...ouraging preclinical data of AV-412, a novel,next.../HER2 using,AVEO,s unique EGFR mutant and drug-res...the preclinical study showed that AV-412,is greate...
Other Medicine Technology:EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR,Annual Meeting 2EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR,Annual Meeting 3EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR,Annual Meeting 4AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral,Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and,Drug-Resistant Lung Cancer 2AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral,Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and,Drug-Resistant Lung Cancer 3AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral,Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and,Drug-Resistant Lung Cancer 4...nterior Spinal Implant system. Material that has a...cal bone. The result is an implant that meets the ..., while optimizing the fusion environment through ...omic design with 5 and 10 degrees of lordosis. Min...
...Cage System provides anterior column support for s...ctomies from T1 to L5. The system consists of one ...tacked to a desired height, accommodating various ...lymer material emulates the biomechanical properti...
The primary goals in interbody fusion are to immobilize the affected vertebrae, to restore disc space height and sagittal alignment, and to provide an enviroment for bone fusion between vertebral bod
Flexoscope images are transmitted through sorted fiberglass bundles that record the picture and transmit it to a user's eye. Karl Storz flexoscopes are designed for rough, industrial handling and can
Medicine Products: